A Phase 3 Trial to Look at the Safety and Effectiveness of Ustekinumab in Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis
Clinical trial NCT00747344 · COMPLETED
Trial details
- NCT number
- NCT00747344
- Sponsor
- Centocor, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2009-09-01
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.